Also, they have a clinical development centre in Bangalore. GlaxoSmithKline Pharma Limited was incorporated in November 13, 1924. During year 1956, the Company began primary production of vaccines ...

Also, they expanded the Anti TB Facility at KRS Gardens, Bangalore. The company increased ... GIaxoSmithKline, UK (GSK). In terms of the agreement, OTL will license intellectual property and ...

The midcap fund added 7.43 lakh shares of United Breweries and approximately 5.87 lakh shares of Premier Energies to its portfolio during the mentioned period.

Five years later, Dr. Reddy's Laboratories acquired the US penicillin facility and products of GlaxoSmithKline ... Laboratories are listed on BSE, NSE, Bangalore Stock Exchange, Calcutta Stock ...

Learn More. Just over a year ago, I ran the rule over GSK (LSE: GSK) shares. They looked very cheap and were offering a growing dividend. However, I chose instead to invest in FTSE 100 ...

With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its own. The British Big Pharma has filed depemokimab for FDA approval ...

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it revealed (PDF) that Walmsley took a 16% pay cut in 2024, it also laid out a new compensation ...

LONDON, Feb 27 (Reuters) - British drugmaker GSK (GSK.L), opens new tab will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such ...

GSK (GSK) announced the US Food and Drug Administration, FDA, has accepted for review the Biologics License Application, BLA, for the use of depemokimab in two indications. The proposed ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best vaccine stocks to buy now. On February 24, CNBC reported that President Trump declared that ...

Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big Pharma after GSK (NYSE:GSK) to revise DEI initiatives amid the Trump ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...